4.6 Article

Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses

Related references

Note: Only part of the references are listed.
Article Cell Biology

Antimicrobial Peptide LL-37 and IDR-1 Ameliorate MRSA Pneumonia in Vivo

Man Hou et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)

Article Biotechnology & Applied Microbiology

The human cathelicidin LL-37 inhibits influenza A viruses through a mechanism distinct from that of surfactant protein D or defensins

Shweta Tripathi et al.

JOURNAL OF GENERAL VIROLOGY (2013)

Article Multidisciplinary Sciences

The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus

Silke M. Currie et al.

PLOS ONE (2013)

Article Immunology

Human H-Ficolin Inhibits Replication of Seasonal and Pandemic Influenza A Viruses

Anamika Verma et al.

JOURNAL OF IMMUNOLOGY (2012)

Review Cell Biology

Human defensins and LL-37 in mucosal immunity

Mona Doss et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Structures of Human Host Defense Cathelicidin LL-37 and Its Smallest Antimicrobial Peptide KR-12 in Lipid Micelles

Guangshun Wang

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Immunology

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses

Patrick C. Reading et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Virology

Inhibition of influenza viral neuraminidase activity by collectins

T. Tecle et al.

ARCHIVES OF VIROLOGY (2007)

Article Biochemistry & Molecular Biology

Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin

Kenshi Yamasaki et al.

FASEB JOURNAL (2006)

Article Critical Care Medicine

Increased levels of antimicrobial peptides in tracheal aspirates of newborn infants during infection

S Schaller-Bals et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)